Rodrigo Ramos

Life Sciences

Few people can say that as children they dreamed of curing cancer. Rodrigo Ramos told his parents exactly that from the age of seven. A biologist from Universidade Estadual Paulista Júlio de Mesquita Filho, Rodrigo also holds a master’s degree in immunology from the University of São Paulo (USP). He also completed his doctorate in immunology at USP and has a second doctorate from the Université de Lyon 1 in France. He carried out his postdoctoral research at the Cancer Immunotherapy Center at the Curie Institute, Paris, and was also a researcher at the Centre de Recherche des Cordeliers/Sorbonne Université in France.

After a long period in Europe, Rodrigo returned to Brazil and now lives in São Paulo with his wife and four-year-old son, Thomas. His current project is an innovative investigation into the early diagnosis of cancer. To clear his head from data processing and articles, Rodrigo often buries his feet in the sand on the beach with friends or cheers at a Santos match. Passionate about Brazilian music, the biologist also dabbles in guitar and percussion.

Open Calls

Science Call 5
Array
(
    [0] => WP_Post Object
        (
            [ID] => 13479
            [post_author] => 10
            [post_date] => 2023-07-24 18:43:23
            [post_date_gmt] => 2023-07-24 18:43:23
            [post_content] => This project aims to address cytokine release syndrome (CRS) in patients treated with CAR-T cells, which are used in cancer immunotherapy. The project proposes using nanomaterial-based biosensors, such as graphene or metallic nanoparticles, to detect the presence of IL-6 early and predict the occurrence of CRS, allowing for early treatment of toxic reactions. This approach aims to reduce severe clinical events, hospitalization time, and drug costs, benefiting patients’ health and reducing expenses for the public health system (SUS).
            [post_title] => Development of a predictive biosensor for Cytokine release syndrome
            [post_excerpt] => 
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => desenvolvimento-de-um-biossensor-para-predizer-a-sindrome-de-liberacao-de-citocinas-em-pacientes-oncologicos-tratados-por-celulas-car-t
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2026-02-12 19:17:42
            [post_modified_gmt] => 2026-02-12 19:17:42
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://serrapilheira.org/?post_type=projeto&p=13479
            [menu_order] => 0
            [post_type] => projeto
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

)

Projects

Development of a predictive biosensor for Cytokine release syndrome
Chemistry, Life Sciences

This project aims to address cytokine release syndrome (CRS) in patients treated with CAR-T cells, which are used in cancer immunotherapy. The project proposes using nanomaterial-based biosensors, such as graphene or metallic nanoparticles, to detect the presence of IL-6 early and predict the occurrence of CRS, allowing for early treatment of toxic reactions. This approach aims to reduce severe clinical events, hospitalization time, and drug costs, benefiting patients’ health and reducing expenses for the public health system (SUS).

Amount invested

Grant 2023: R$ 31.915,00
  • Topics
  • câncer
  • diagnóstico
  • imunologia